肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗

2017-12-12 欧洲核医学协会 Eur J Nucl Med Mol Imaging. 2017 Dec 12.

前列腺癌镭-233放射治疗

2017年12月，欧洲核医学协会(EANM)发布了转移性去势难治性前列腺癌应用镭-233放射治疗指南。指南主要目的是为核医学专家在评估应用镭-233放射治疗以及放射治疗期间的患者管理提供指导建议。

中文标题：

2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗

英文标题：

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer

发布机构：

欧洲核医学协会

发布日期：

2017-12-12

简要介绍：

2017年12月，欧洲核医学协会(EANM)发布了转移性去势难治性前列腺癌应用镭-233放射治疗指南。指南主要目的是为核医学专家在评估应用镭-233放射治疗以及放射治疗期间的患者管理提供指导建议。

 

拓展指南：与前列腺癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗)] GetToolGuiderByIdResponse(projectId=1, id=342ff1c0015353aa, title=2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗, enTitle=EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer, guiderFrom=Eur J Nucl Med Mol Imaging. 2017 Dec 12., authorId=null, author=, summary=2017年12月，欧洲核医学协会(EANM)发布了转移性去势难治性前列腺癌应用镭-233放射治疗指南。指南主要目的是为核医学专家在评估应用镭-233放射治疗以及放射治疗期间的患者管理提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=401, associationName=欧洲核医学协会, associationIntro=欧洲核医学协会成立于1985年9月6日，是一个非营利性的专业医疗协会，已经拥有超过3000名会员涉及临床医生、科学家以及专业领域的相关工作人员。协会主要致力于促进整个欧洲及欧洲以外核医学的发展。, copyright=0, guiderPublishedTime=Tue Dec 12 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年12月，欧洲核医学协会(EANM)发布了转移性去势难治性前列腺癌应用镭-233放射治疗指南。指南主要目的是为核医学专家在评估应用镭-233放射治疗以及放射治疗期间的患者管理提供指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>前列腺癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=683591c001529a48" title="2017 HKUA/HKSUO共识声明：转移性前列腺癌的管理" target=_blank>2017 HKUA/HKSUO共识声明：转移性前列腺癌的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c72151c001512170" title="中国前列腺癌外科治疗专家共识" target=_blank>中国前列腺癌外科治疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=321f71c001509ee9" title="2017 CUA指南：前列腺癌筛查和早期诊断建议" target=_blank>2017 CUA指南：前列腺癌筛查和早期诊断建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3e5131c001a99557" title="NCCN临床实践指南：前列腺癌早期检测（2017.V2）" target=_blank>NCCN临床实践指南：前列腺癌早期检测（2017.V2）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=665bf1c001a8624e" title="2017 EAU/ESTRO/ESUR/SIOG指南：前列腺癌" target=_blank>2017 EAU/ESTRO/ESUR/SIOG指南：前列腺癌</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" target=_blank>有关前列腺癌更多指南</a></ul>, tagList=[TagDto(tagId=781, tagName=前列腺癌), TagDto(tagId=66880, tagName=镭-233), TagDto(tagId=6811, tagName=放射治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7204, appHits=132, showAppHits=0, pcHits=5007, showPcHits=3125, likes=132, shares=3, comments=14, approvalStatus=1, publishedTime=Sat Dec 23 23:01:22 CST 2017, publishedTimeString=2017-12-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 23 23:01:22 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:21:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗)])
2017 EANM指南：转移性去势难治性前列腺癌应用镭-233放射治疗
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=312266, encodeId=7969312266b5, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43281712921, createdName=刀锋剑客, createdTime=Sat May 05 16:57:42 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273642, encodeId=01ac2e36421a, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Dec 29 22:51:43 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273195, encodeId=ba232e3195ae, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Thu Dec 28 11:18:49 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272698, encodeId=1fd82e26986a, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Dec 26 16:58:20 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272636, encodeId=84772e2636f5, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Tue Dec 26 12:08:03 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2018-05-05 刀锋剑客

    好好学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=312266, encodeId=7969312266b5, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43281712921, createdName=刀锋剑客, createdTime=Sat May 05 16:57:42 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273642, encodeId=01ac2e36421a, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Dec 29 22:51:43 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273195, encodeId=ba232e3195ae, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Thu Dec 28 11:18:49 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272698, encodeId=1fd82e26986a, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Dec 26 16:58:20 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272636, encodeId=84772e2636f5, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Tue Dec 26 12:08:03 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-29 1e0e5697m83(暂无匿称)

    henhao

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=312266, encodeId=7969312266b5, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43281712921, createdName=刀锋剑客, createdTime=Sat May 05 16:57:42 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273642, encodeId=01ac2e36421a, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Dec 29 22:51:43 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273195, encodeId=ba232e3195ae, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Thu Dec 28 11:18:49 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272698, encodeId=1fd82e26986a, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Dec 26 16:58:20 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272636, encodeId=84772e2636f5, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Tue Dec 26 12:08:03 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-28 1e0e5a1fm42(暂无匿称)

    henhao

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=312266, encodeId=7969312266b5, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43281712921, createdName=刀锋剑客, createdTime=Sat May 05 16:57:42 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273642, encodeId=01ac2e36421a, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Dec 29 22:51:43 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273195, encodeId=ba232e3195ae, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Thu Dec 28 11:18:49 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272698, encodeId=1fd82e26986a, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Dec 26 16:58:20 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272636, encodeId=84772e2636f5, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Tue Dec 26 12:08:03 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-26 xiaotao112411

    学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=312266, encodeId=7969312266b5, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43281712921, createdName=刀锋剑客, createdTime=Sat May 05 16:57:42 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273642, encodeId=01ac2e36421a, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Dec 29 22:51:43 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273195, encodeId=ba232e3195ae, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Thu Dec 28 11:18:49 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272698, encodeId=1fd82e26986a, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Tue Dec 26 16:58:20 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272636, encodeId=84772e2636f5, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Tue Dec 26 12:08:03 CST 2017, time=2017-12-26, status=1, ipAttribution=)]
    2017-12-26 139****0239

    henhao

    0

相关指南

中国前列腺癌外科治疗专家共识

中国抗癌协会泌尿肿瘤专业委员会 · 2017-10-20

2017 EAU/ESTRO/ESUR/SIOG指南：前列腺癌

欧洲泌尿外科学会(EAU,European Association of Urology) · 2017-03-01

2017 SIOG推荐建议：老年前列腺癌的管理

国际老年肿瘤学会(SIOG,International Society of Geriatric Oncology) · 2017-01-11

转移性前列腺癌化疗中国专家共识（2017版）

中华医学会泌尿外科学分会(CUA) · 2017-03-30

2016 JUA循证临床实践指南：前列腺癌

日本泌尿外科协会(JUA,Japanese Urological Association) · 2016-10-01

前列腺癌近距离放射治疗指南（巴西） 2017

巴西放疗协会 · 2017-06-24